- Home
- Products
- Customized FluoroAb™
- PTK7
- Anti-PTK7 MAb (Clone 2)-iFluor® 405 Succinimidyl Ester
Anti-PTK7 MAb (Clone 2)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2602)
This product is comprised of an Humanized Anti-PTK7 IgG1-kappa (Clone 2) labeled with iFluor® 405 Succinimidyl Ester. iFluor® 405 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- PTK7
- Overview
- Humanized Anti-PTK7 IgG1-kappa (Clone 2)
- Species Reactivity
- Human
- Name
- iFluor® 405 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 403/427
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS2602. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-560 | Anti-PTK7-VC-auristatin ADC | VC (valine-citrulline) | Auristatin |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-EGFR MAb (Clone 23)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5463)
- Anti-C5 MAb (Clone 26)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS10876)
- Anti-CD33 MAb (Clone 23)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8722)
- Anti-ANGPT2 MAb (Clone 5)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13381)
- Anti-ERBB2 MAb (Clone 32)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3980)
- Anti-DLL4 MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS1738)
- Anti-C. albicans Hsp90 MAb (Clone 1)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13060)
- Anti-IFNA1 MAb (Clone 6)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13582)
- Anti-STEAP1 MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6695)
- Anti-CD40 MAb (Clone 17)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11953)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.